Readmissions in the postoperative period following urinary diversion by John L. Gore et al.
World J Urol (2011) 29:79–84
DOI 10.1007/s00345-010-0613-8
TOPIC PAPER
Readmissions in the postoperative period following urinary 
diversion
John L. Gore · Julie Lai · Scott M. Gilbert · 
The Urologic Diseases in America Project
Received: 11 September 2010 / Accepted: 2 November 2010 / Published online: 23 November 2010
© The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract
Purpose Most analyses of complications after urinary
diversion are restricted to the index admission. Given the
complexity of these reconstructions, readmissions occur
commonly. We sought to characterize the burden and
impact of readmissions in the postoperative period follow-
ing urinary diversion.
Methods Using 5% Medicare data for the years 1998–
2005, we identiWed patients undergoing ileal conduit, conti-
nent, and other urinary diversions for benign and malignant
indications. We examined the 90-day rates of readmission
and evaluated factors associated with readmission after uri-
nary diversion, either to the primary hospital or to a second-
ary facility. We assessed 90-day and 2-year mortality after
urinary diversion and incorporated readmission status as a
covariate in these multivariable models.
Results Our study sample included 1,565 patients, of
whom 491 patients (31%) were readmitted within 90 days
of their urinary diversion. Patients readmitted after urinary
diversion had higher comorbidity count than those not read-
mitted (59% of those readmitted with comorbidity count at
least 1 versus 50% of those not readmitted, P = 0.002).
Other clinical and demographic characteristics did not
diVer by readmission status (P > 0.12 for age, race, type of
urinary diversion, and primary diagnosis). Complication
rates were higher in readmitted patients than those not
readmitted; 2-year mortality was associated with 90-day
readmission status—18.8% of readmitted versus 12.8%
of not readmitted patients died within 2 years of surgery
(P = 0.003).
Conclusions Readmissions occur commonly after uri-
nary diversion. Many readmitted patients have complica-
tions of complex surgery managed at secondary hospitals,
which may portend a quality concern that merits further
study.
Keywords Bladder cancer · Urinary diversion · 
Neobladder · Complications · Readmission · Quality of care
Introduction
Despite advances in reconstructive technique, urinary
diversion remains a morbid procedure. Complication rates
range from 18 to 37% [1–3] with quoted mortality rates
ranging from 2 to 7% [4–6]. Most analyses are restricted to
the immediate postoperative period, [3, 7–9] yet a large
burden of the health care utilization after urinary diversion
continues beyond the index admission. Patients often
require multiple clinic visits for teaching, nursing care, and
medical management of comorbid conditions [2]. Further,
many of the complications of urinary diversion are severe
enough to warrant readmission.
Readmissions are common after complex surgery [10–12].
As complex surgeries increasingly shift to large urban
teaching hospitals, as has occurred for cystectomy and
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patient outcomes. In gastrectomy patients, for example,
readmission to secondary hospitals—hospitals other than
the index surgical hospital—is associated with worse mor-
tality outcomes [14]. Secondary hospitals may have fewer
resources to manage complications associated with com-
plex surgeries.
We sought to characterize the burden of readmissions in
the postoperative period following urinary diversion. We
further sought to understand the impact of the site of read-
mission on patient outcomes. Herein, we describe the inci-
dence and associated factors for readmission after urinary
diversion both to the hospital where surgery was performed
as well as to secondary hospitals.
Methods
Study sample
We accessed a 5% sample of Medicare claims for the study
years 1998–2005 to identify men and women undergoing
urinary diversion. Medicare data are predominantly com-
prised of claims from beneWciaries enrolled on the basis of
age greater than 65 years, but also include those with dis-
abling conditions such as end stage renal disease. Medicare
data include inpatient and outpatient claims submitted by
health care providers and facilities. We derived our patient
sample from the Medicare Provider Analysis and Review
(MEDPAR) inpatient services Wle and the outpatient pro-
vider claims Carrier Wle and abstracted patient demographic
characteristics from the Denominator Wle.
We identiWed men and women undergoing urinary diver-
sion for benign and malignant indications from Interna-
tional ClassiWcation of Diseases, 9th Revision (ICD-9) and
Common Procedural Treatment, 4th Revision (CPT) codes.
Type of urinary diversion was identiWed with ICD-9 codes
and CPT codes as well and categorized into ileal conduit
and continent diversion groups. Other urinary diversions
included ureterosigmoidostomy patients (ICD-9 code
56.71, CPT code 50810) and those undergoing enterocy-
stoplasty (ICD-9 code 57.87, CPT code 50825, 51960). We
did not restrict the sample by age, as many beneWciaries
admitted younger than 65 years of age have conditions pre-
disposing to a higher likelihood of urinary reconstruction,
such as renal failure. We excluded patients without both
Medicare Part A and Part B coverage and those enrolled in
Medicare Health Maintenance Organization (HMO) pro-
grams. We further restricted our sample to those patients
with at least 1 year of enrollment prior to their urinary
diversion and 2 years of enrollment after surgery. This per-
mitted comprehensive assessment of antecedent comorbid
conditions and postsurgical complications.
We determined patient age, gender, race, US Census
region of residence, and date of death, if applicable, from
the Denominator Wles. We used the Klabunde modiWcation
of the Charlson comorbidity index to enumerate patient
comorbidities [15].
Outcome measures
We examined 90-day outcomes to evaluate the manage-
ment of perioperative complications. Urinary diversions are
rarely performed as staged procedures, thus early postoper-
ative readmissions are unlikely to be related to subsequent
elective procedures. Surgical and medical complications
selected a priori from prior retrospective reviews of
complications after urinary diversion included stomal
complications, wound complications, urinary obstruction,
urolithiasis, urinary Wstulae, infectious complications, and
renal failure. These outcomes of interest were Xagged using
relevant ICD-9 codes in the MEDPAR and Carrier Wles. We
examined inpatient readmissions in the 90 days following
urinary diversion and used the providing hospitals unique
identiWer to attribute the initial readmission to the primary
hospital (i.e., the hospital where the surgery was performed)
or to a secondary hospital.
Statistical analysis
We compared patients undergoing urinary diversion by
type of reconstruction and need for readmission with Chi-
squared analysis for categorical variables and analysis of
variance and independent samples t-tests for continuous
variables. We further compared patients readmitted to their
primary hospital to those readmitted to secondary facilities
with Chi-squared analysis for categorical variables and
independent samples t-tests for continuous variables. We
compared 90-day complication rates by readmission hospi-
tal with Chi-squared analysis.
To understand whether readmission aVects early and
intermediate mortality outcomes after urinary diversion, we
performed univariate survival analyses to examine 90-day
and 2-year survival outcomes. We created multivariable
Cox proportional hazards models to evaluate factors inde-
pendently associated with 90-day and 2-year mortality. In
addition to 90-day readmission status (categorized as not
readmitted, readmitted to primary hospital, and readmitted
to secondary hospital), we adjusted our survival analyses
for patient age, gender, history of bladder cancer, and level
of comorbidity.
The study was reviewed and approved by the University
of California, Los Angeles (UCLA) and RAND corporation
Institutional Review Board (IRB). All statistical analyses
were performed with SAS 9.2 (SAS Corporation, Cary,
NC).123
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We identiWed 1,565 patients who underwent urinary diver-
sion for benign and malignant indications between 1998
and 2005. Table 1 displays the characteristics of the study
sample. Patients undergoing continent urinary diversion
were younger and had fewer comorbidities than those
undergoing ileal conduit or other reconstructions. A major-
ity of patients receiving ileal conduit urinary diversions had
bladder cancer as their primary diagnosis compared with
continent and other reconstructions, where benign indica-
tions predominated.
Of our sample, 491 patients (31%) were readmitted
within 90 days of their urinary diversion. Of those, 365
patients (74%) were readmitted once within 90 days of sur-
gery, and the remaining 26% were readmitted two or more
times. Age, gender, race, type of urinary diversion, and pri-
mary diagnosis did not diVer between those readmitted and
those not readmitted (P = 0.54, P = 49, P = 0.11, P = 0.13,
and P = 0.50, respectively). Patients readmitted after uri-
nary diversion had higher comorbidity count than those not
readmitted (59% of those readmitted with comorbidity
count at least 1 versus 50% of those not readmitted,
P = 0.002). Similarly, among those readmitted, age, race,
type of urinary diversion, and primary diagnosis did not
diVer between those readmitted to the primary hospital
compared with those readmitted to secondary facilities
(P = 0.12, P = 0.68, P = 0.40, and P = 0.57, respectively).
Comorbidity likewise did not diVer by readmission hospital
(P = 0.87). A trend was observed toward readmission to the
primary hospital among men (67% of men vs. 59% of
women, P = 0.08) and those in the Northeast and South,
(73% of Northeastern, 67% of Southern, 60% of Midwest-
ern, and 56% of Western diversion patients, P = 0.07).
Patients readmitted to secondary hospitals had higher
lengths of stay for their initial readmission than patients read-
mitted to their primary hospital (lengths of stay 8.7 §
11.0 days vs. 6.6 § 8.6 days, P = 0.02, respectively). Table 2
displays complications rates stratiWed by readmission status.
Sepsis and hernia were suYciently rare in the postoperative
period to prohibit inclusion in the analysis. Patients not
requiring readmission beyond the index hospitalization had
substantially lower rates of the complications analyzed than
those readmitted. Those readmitted to secondary hospitals
had higher rates of renal failure, urinary Wstula, and stone dis-
ease than those readmitted to the primary hospital. Wound
Table 1 Characteristics of the 
study sample Ileal conduit Continent Other Total P value
Total, no. 1,248 (80) 105 (7) 212 (13) 1,565
Age, no. (%)
Mean § SD
<65 years 129 (10) 45 (43) 29 (14) 203 (13) <0.001
65–69 183 (15) 17 (16) 13 (18) 239 (15)
70–74 360 (29) 27 (26) 64 (30) 451 (29)
75–79 346 (28) 14 (12) 38 (23) 407 (26)
¸80 230 (18) 3 (3) 32 (15) 265 (17)
Gender, no. (%)
Men 850 (68) 65 (62) 137 (65) 1,052 (67) 0.29
Women 398 (32) 40 (38) 75 (35) 513 (33)
Race/ethnicity, no. (%)
White 1,130 (91) 91 (87) 187 (88) 1,408 (90) 0.29
Nonwhite 118 (9) 14 (13) 25 (12) 157 (10)
Charlson comorbidity index, no. (%)
0 563 (45) 66 (63) 105 (50) 734 (47) 0.03
1 376 (30) 25 (24) 60 (28) 461 (30)
¸2 304 (25) 14 (13) 46 (22) 364 (23)
Primary diagnosis, no. (%)
Bladder cancer 885 (71) 37 (35) 104 (49) 1,026 (66) <0.001
Other 363 (29) 68 (65) 108 (51) 539 (34)
US Census region, no. (%)
Midwest 364 (29) 33 (31) 62 (29) 459 (29) 0.14
Northeast 246 (20) 9 (9) 38 (18) 293 (19)
South 463 (37) 42 (40) 78 (37) 583 (37)
West 175 (14) 21 (20) 34 (16) 230 (15)123
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readmitted to the primary hospital than those not readmitted
and those readmitted elsewhere. Urinary obstruction was
more common among readmitted patients but did not diVer
by readmission hospital. Stomal complications did not diVer
by readmission status but were also infrequent.
In the 90-day postoperative period, 31 patients (2.0%)
died of any cause; 90-day mortality was not associated with
readmission status (90-day mortality 2.0% in those not read-
mitted, 2.3% in those readmitted to the primary facility, and
1.8% in those readmitted to a secondary hospital, P = 0.91).
Within 2 years of diversion, 225 patients (14.6%) died of all
causes. Two-year mortality was more common among
patients readmitted in the perioperative period (18.8% of
readmitted patients vs. 12.8% of those not readmitted,
P = 0.003). Table 3 displays hazard ratios from Cox multi-
variable models of 90-day and 2-year mortality after urinary
diversion. Increasing comorbidity was associated with 90-
day and 2-year mortality after urinary diversion.
Discussion
Our study has several important Wndings. First, a large pro-
portion of Medicare beneWciaries undergo urinary diversion
for benign indications. Urinary diversion is intimately asso-
ciated with bladder cancer: a common indication for lower
urinary tract reconstruction is to follow surgical removal of
the bladder and associated organs for cancer. However, in
our sample, which included those with Medicare younger
than 65 for disabling conditions, roughly a third of our
patients underwent urinary reconstruction for benign dis-
ease. This may have implications for the identiWcation of
data sources to investigate long-term outcomes after uri-
nary diversion as cancer-speciWc datasets may fail to cap-
ture a substantial number of reconstructed patients. Those
with benign conditions were also more likely to undergo
continent urinary diversions. Analysis of national datasets
has revealed underutilization of continent reconstructions
among bladder cancer patients undergoing radical cystec-
tomy [16]. Understanding the processes which facilitate
prioritization of continent diversions among patients with
benign lower urinary tract pathology may aid dissemination
of continent techniques among cancer patients.
Second, readmission in the postoperative period is a
common occurrence and large source of health care utiliza-
tion after urinary diversion. Greater than 30% of the
patients in our study were readmitted within 90 days of sur-
gery. This rate is comparable with patients undergoing
other complex surgical procedures such as colorectal sur-
gery and pancreaticoduodenectomy [10, 11]. Approxi-
mately a quarter of those had multiple readmissions.
Urinary diversion is a morbid procedure, but studies that
focus on the index admission fail to capture a signiWcant
proportion of the morbidity that occurs. Readmissions dis-
proportionately aVect the sickest patients, as comorbidity
was the only clinical or demographic factor signiWcantly
associated with readmission status. This raises concern that
many of these readmissions were for medical complica-
tions. Yet, comorbidity is also associated with surgical
complications [7, 17]. Rigorous attention to preoperative
optimization of speciWc comorbidities with high associa-
tions with the sequelae of urinary diversion, such as chronic
pulmonary disease and poor nutritional status, may lower
readmission rates in more comorbid patients.
Table 2 Readmission facility 
and 90-day complications after 
urinary diversion
Not readmitted Readmitted P value
Primary hospitala Secondary hospital
Total, no. 1,074 (69) 303 (20) 165 (11)
Wound infection, no. (%) 23 (2.1) 29 (9.6) 7 (4.2) <0.001
Renal failure, no. (%) 13 (1.2) 14 (4.6) 16 (9.7) <0.001
Stoma complications, no. (%) 2 (0.2) 2 (0.7) 2 (1.2) 0.10
Urinary Wstula, no. (%) 4 (0.4) 9 (3.0) 9 (5.5) <0.001
Urinary obstruction, no. (%) 15 (1.4) 25 (8.3) 14 (8.5) <0.001
Urolithiasis, no. (%) 1 (0.1) 2 (0.7) 2 (1.2) 0.03
a Primary hospital refers 
to the facility where the urinary 
diversion was performed
Table 3 Intermediate 90-day and short-term 2-year mortality after
urinary diversion
a Primary hospital refers to the facility where the urinary diversion was
performed. Also adjusted for age, gender, race
Hazard ratio (95% CI) 90-day mortality 2-year mortality
90-day readmission status (vs. not readmitted)
Readmitted to primary 
hospitala
1.10 (0.46–2.63) 1.52 (1.11–2.09)
Readmitted to secondary 
hospital
0.81 (0.23–2.77) 1.46 (0.98–2.16)
Comorbidity index (vs. 0)
1 2.09 (0.76–5.74) 1.37 (1.00–1.87)
¸2 4.77 (1.91–11.9) 1.54 (1.11–2.15)123
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readmission to the hospital where surgery was performed
was not associated with patient demographic characteris-
tics. We anticipated, given the natural regionalization of
cystectomy that occurred during the 1990s, [13] that uri-
nary diversion patients readmitted to secondary facilities
represent regionalized patients: patients referred to tertiary
hospitals by urologists that do not perform radical cystec-
tomy. As such, there may be demographic diVerences in the
constituencies of readmitted patients stratiWed by the read-
mission hospital. We identiWed a trend toward gender and
regional diVerences. Gender diVerences may reXect the
stronger support oVered to male cancer patients by their
partners than female cancer patients by their partners, [18]
while regional diVerences may reXect the geographic con-
centration of urban areas in the Northeast and South com-
pared with the Midwest and especially the West. Most
cystectomies—and by proxy most urinary diversions—are
performed in urban teaching hospitals; the expanse of the
West may explain fewer readmissions to the primary hospi-
tal in this region. Strategies for organized regionalization of
cystectomy care for bladder cancer should consider geo-
graphic diVerences in the concentration of tertiary referral
centers.
Lastly, complication rates, as expected, were more com-
mon among readmitted patients. The complications likely
drove the readmissions, as few of the complications ana-
lyzed may be managed in an ambulatory setting. The hospi-
tal at which patients were readmitted may be a proxy for
patient access to care. Primary hospitals may be more diY-
cult to access among regionalized patients following sur-
gery as secondary hospitals may be the closest medical
facilities to patients requiring urgent medical attention.
Although certain complications were more common at pri-
mary hospitals, severe complications such as renal failure
and urinary Wstula were more common at secondary hospi-
tals. The sequelae of these more substantial complications
may explain the higher 2-year mortality rates among
patients readmitted to secondary facilities. Secondary facil-
ities may have a lower comfort level managing the compli-
cations of complex cancer surgery, or reduced ancillary
resources such as interventional radiology to aid with man-
aging those complications. Further studies should investi-
gate the outcomes of diversion-related complications
stratiWed by the facility at which they are treated. Second-
ary hospitals may be low volume hospitals and, thus,
regionalization of the complications of urinary diversion
may be required to optimize 90-day outcomes. Our data
show, at least, that 90-day survival is not compromised
regardless of the readmission hospital.
Our study has numerous limitations. As the study of
readmissions after urinary diversion has been limited, we
chose to focus our analysis on simple description of the
magnitude of the problem. However, we had limited can-
cer-speciWc information in this Medicare dataset and could
not account for the severity of the cancer in our analyses.
Patients with higher stage cancers often receive chemother-
apy after surgery which may explain some of the readmis-
sions. Our focus on Medicare beneWciaries may limit the
generalizability of our results. Although the majority of
bladder cancer patients are of Medicare age, [19] patients
with benign lower urinary tract pathology that requires uri-
nary diversion comprise a diverse age range. Our results
may be speciWc to older and disabled patients undergoing
urinary diversion and may not extrapolate to younger
healthier patients. Also, in using readmission status as a pri-
mary regressor in our survival analyses, we may be biased
toward better survival in readmitted patients. Those read-
mitted had to survive long enough to require readmission.
Lastly, we restricted our sample to those with complete
claims data for a 2-year postoperative period. This strict
inclusion criteria may have reduced our sample to a select
cohort that under or overestimates the incidence of compli-
cations following urinary diversion.
Despite these limitations, we characterized the incidence
of readmissions after urinary diversion and identiWed a pos-
sible quality of care concern with regard to readmissions to
secondary facilities. Readmissions within 90 days of uri-
nary diversion confound the care of a third of patients
undergoing these reconstructions, evidence of the immense
burden of these reconstructions on the patients. Of those,
over half get readmitted to secondary hospitals, rather than
the hospital at which surgery was performed. Those read-
mitted to secondary institutions may have worse down-
stream outcomes, as their secondary hospital readmission
may evince reduced access to care. Strategies to regionalize
complex surgical care must balance the beneWt of having
surgery at a high volume institution with the consequences
of that regionalization. The potential for quality concerns
related to readmissions speciWcally to secondary hospitals
merits further study.
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